Financials Neuberger Berman High Yield Strategies Fund Inc.
Equities
NHS
US64128C1062
Closed End Funds
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.93 USD | -0.25% | +0.38% | +2.72% |
Valuation
Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 201.9 | 233.1 | 210.1 | 257.2 | 159.5 | 136.8 |
Enterprise Value (EV) 1 | 326.7 | 357.3 | 337.7 | 362.2 | 281.4 | 242.8 |
P/E ratio | -65.3 x | 10.3 x | 69.5 x | 7.2 x | -4.76 x | 49.1 x |
Yield | 7.97% | 7.86% | 10.1% | 8.25% | 13.2% | 15.4% |
Capitalization / Revenue | 9.04 x | 9.81 x | 9.75 x | 15.8 x | 9.03 x | 6.12 x |
EV / Revenue | 14.6 x | 15 x | 15.7 x | 22.2 x | 15.9 x | 10.9 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | 27.8 x | 45.1 x | 61.9 x | 28.8 x | 54.2 x | 78.3 x |
FCF Yield | 3.6% | 2.22% | 1.61% | 3.47% | 1.84% | 1.28% |
Price to Book | 0.83 x | 0.94 x | 0.92 x | 1.07 x | 0.95 x | 0.94 x |
Nbr of stocks (in thousands) | 19,541 | 19,541 | 19,541 | 19,541 | 19,433 | 19,438 |
Reference price 2 | 10.33 | 11.93 | 10.75 | 13.16 | 8.210 | 7.040 |
Announcement Date | 1/7/19 | 1/6/20 | 1/7/21 | 1/5/22 | 1/5/23 | 1/5/24 |
Income Statement Evolution (Annual data)
Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 22.33 | 23.76 | 21.53 | 16.32 | 17.66 | 22.35 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | 19.37 | 20.3 | 17.98 | 13.69 | 15.42 | 19.8 |
Operating Margin | 86.76% | 85.43% | 83.5% | 83.89% | 87.28% | 88.6% |
Earnings before Tax (EBT) 1 | -3.093 | 22.53 | 3.022 | 26.8 | -33.49 | 3.718 |
Net income 1 | -3.093 | 22.53 | 3.022 | 26.8 | -33.49 | 3.718 |
Net margin | -13.85% | 94.8% | 14.03% | 164.18% | -189.61% | 16.63% |
EPS 2 | -0.1583 | 1.153 | 0.1546 | 1.828 | -1.723 | 0.1434 |
Free Cash Flow 1 | 11.77 | 7.925 | 5.452 | 12.57 | 5.192 | 3.101 |
FCF margin | 52.71% | 33.35% | 25.32% | 77.03% | 29.4% | 13.87% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | 35.18% | 180.41% | 46.92% | - | 83.41% |
Dividend per Share 2 | 0.8231 | 0.9378 | 1.086 | 1.086 | 1.086 | 1.086 |
Announcement Date | 1/7/19 | 1/6/20 | 1/7/21 | 1/5/22 | 1/5/23 | 1/5/24 |
Balance Sheet Analysis
Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 125 | 124 | 128 | 105 | 122 | 106 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 11.8 | 7.93 | 5.45 | 12.6 | 5.19 | 3.1 |
ROE (net income / shareholders' equity) | -1.22% | 9.18% | 1.27% | 13.1% | -19.2% | 2.05% |
ROA (Net income/ Total Assets) | 3.14% | 3.33% | 3.02% | 2.62% | 3.28% | 4.13% |
Assets 1 | -98.64 | 675.8 | 99.94 | 1,022 | -1,022 | 89.99 |
Book Value Per Share 2 | 12.50 | 12.70 | 11.70 | 12.30 | 8.660 | 7.500 |
Cash Flow per Share 2 | 0 | 0.0400 | 0 | - | - | - |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 1/7/19 | 1/6/20 | 1/7/21 | 1/5/22 | 1/5/23 | 1/5/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+2.72% | 206M | |
+3.74% | 12.61B | |
+5.50% | 9.01B | |
-3.20% | 5.41B | |
+2.44% | 5.25B | |
+5.63% | 5.19B | |
+14.36% | 4.48B | |
+16.67% | 4.44B | |
+1.53% | 4B | |
+1.56% | 3.75B |
- Stock Market
- Equities
- NHS Stock
- Financials Neuberger Berman High Yield Strategies Fund Inc.